Edition:
United Kingdom

Dare Bioscience Inc (DARE.OQ)

DARE.OQ on NASDAQ Stock Exchange Capital Market

1.00USD
18 Sep 2018
Change (% chg)

$0.08 (+8.68%)
Prev Close
$0.92
Open
$0.91
Day's High
$1.00
Day's Low
$0.91
Volume
2,815
Avg. Vol
43,212
52-wk High
$3.58
52-wk Low
$0.75

Latest Key Developments (Source: Significant Developments)

Dare Bioscience Files Prospectus Related To Offer, Sale Of Up To 3.7 Million Shares Of Common Stock
Friday, 24 Aug 2018 

Aug 24 (Reuters) - Dare Bioscience Inc ::DARE BIOSCIENCE FILES PROSPECTUS RELATED TO OFFER, SALE OF UP TO 3.7 MILLION SHARES OF COMMON STOCK UNDERLYING WARRANTS WITH PRICE OF $3.00 .  Full Article

Dare Bioscience Files For A Mixed Shelf Offering Of Up To $60 Mln
Friday, 24 Aug 2018 

Aug 24 (Reuters) - Dare Bioscience Inc ::DARE BIOSCIENCE FILES FOR A MIXED SHELF OFFERING OF UP TO $60 MILLION .  Full Article

Daré Bioscience Enters Into Agreement To Acquire Product To Address Vulvar And Vaginal Atrophy In Hormone Receptor-Positive Breast Cancer Patients
Monday, 7 May 2018 

May 7 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE, INC. ENTERS INTO AGREEMENT TO ACQUIRE PRODUCT TO ADDRESS VULVAR AND VAGINAL ATROPHY IN HORMONE RECEPTOR-POSITIVE BREAST CANCER PATIENTS.DARE BIOSCIENCE INC - DARÉ HAS ENTERED INTO AGREEMENT TO SECURE RIGHTS, CURRENTLY OWNED BY PEAR TREE, TO DEVELOP PT-101.  Full Article

Dare Bioscience Announces Development And Option Agreement With Orbis Biosciences For Long-Acting Injectable Contraceptive
Monday, 12 Mar 2018 

March 12 (Reuters) - Dare Bioscience Inc ::DARÉ BIOSCIENCE ANNOUNCES EXCLUSIVE DEVELOPMENT AND OPTION AGREEMENT WITH ORBIS BIOSCIENCES FOR LONG-ACTING INJECTABLE CONTRACEPTIVE.DARE BIOSCIENCE - AGREEMENT TERMS WITH ORBIS PROVIDE CO OPTION TO ENTER LICENSE AGREEMENT FOR ORB-204 & ORB-214 SHOULD DEVELOPMENT EFFORTS SUCCEED.  Full Article

Dare Bioscience Says Entered Into Common Stock Sales Agreement
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Dare Bioscience Inc ::DARE BIOSCIENCE SAYS ON JANUARY 4, 2018, CO ENTERED INTO COMMON STOCK SALES AGREEMENT - SEC FILING.DARE BIOSCIENCE - UNDER AGREEMENT, CO MAY OFFER AND SELL SHARES OF COMMON STOCK HAVING OFFERING PRICE OF UP TO $10 MILLION.  Full Article

BRIEF-Daré Bioscience Appoints John Fair To Chief Business Officer

* DARÉ BIOSCIENCE, INC. EXPANDS LEADERSHIP TEAM, APPOINTING JOHN FAIR TO CHIEF BUSINESS OFFICER Source text for Eikon: Further company coverage: